CSIMarket Company Name, Ticker, Customers, else..
 

Portage Biotech Inc   (NASDAQ: PRTG)

Portage Biotech Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

PRTG Sales vs. its Competitors Q4 2025


Comparing the current results to its competitors, Portage Biotech Inc reported Revenue decrease in the 4 quarter 2025 year on year by 0 %, despite the revenue increase by the most of its competitors of 3.47 %, recorded in the same quarter.

• List of PRTG Competitors





Revenue Growth Comparisons




Net Income Comparison

Portage Biotech Inc , slower than the average decrease reported by the company's competitors of -5.86 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -5.86 %

<<  PRTG Stock Performance Comparisons


Portage Biotech Inc 's Comment on Competition and Industry Peers


The market for PD-1 antibodies includes at least 14 approved products, with participation from every major pharmaceutical company. Extending the applications of PD-1 antibodies presents potential opportunities for companies seeking to increase market share. The company competes with established large pharmaceutical firms in the pharmaceutical and biotherapeutic development sectors.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Portage Biotech Inc




Adlai Nortye Ltd
Share Performance



+802.91%
One Year
Adlai Nortye Ltd
Profile

Adlai Nortye Ltd. is a holding company incorporated in the Cayman Islands, with subsidiaries operating in the United States and China.

More about Adlai Nortye Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,489.691 mill. $ 6.472 mill. $ -35.528 mill.


Ibio inc
Share Performance



+46.91%
One Year
Ibio inc
Profile

Ibio Inc is a plant-based biologics company that focuses on the development and manufacturing of therapeutic proteins. They utilize their proprietary plant-based expression system to produce biotherapeutics quickly and cost-effectively. By leveraging their platform, Ibio aims to address unmet medical needs and provide affordable and accessible treatments to patients worldwide.

More about Ibio inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 123.831 mill. $ - mill. $ -33.044 mill.


Petros Pharmaceuticals inc
Share Performance



0.00%
Over The Past 5 Days
Petros Pharmaceuticals inc
Profile

Petros Pharmaceuticals Inc is a pharmaceutical company that operates on a business model focused on the research, development, and commercialization of innovative drugs and therapeutics. They strive to bring new solutions to market by leveraging their expertise in various therapeutic areas, ultimately aiming to improve patient outcomes and well-being.

More about Petros Pharmaceuticals inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.284 mill. $ - mill. $ -2.738 mill.


Nextcure Inc
Share Performance



-12.86%
30 Days
Nextcure Inc
Profile

NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need.

More about Nextcure Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 26.973 mill. $ - mill. $ -42.748 mill.


Bolt Biotherapeutics Inc
Share Performance



-8.67%
30 Days
Bolt Biotherapeutics Inc
Profile

Bolt Biotherapeutics Inc's business model focuses on developing novel immunotherapies for the treatment of cancer.

More about Bolt Biotherapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6.052 mill. $ 4.700 mill. $ -28.739 mill.

49 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Portage Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Portage Biotech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.